Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Synthetic Anti-infective Drugs >  Quinolones >  Tosufloxacin

Tosufloxacin

Basic information Safety Supplier Related

Tosufloxacin Basic information

Product Name:
Tosufloxacin
Synonyms:
  • 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid
  • Tosufloxacin
  • Tosufloxacin Tosyiate
  • 7-(3-Amino-1-pyrrolidinyl)-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid
  • dl-Tosufloxacin
  • TOSUFLOXACIN(SUBJECTTOPATENTFREE)
  • Tosufloxacin USP/EP/BP
  • 4-difluorophenyl)-6-fluoro-4-oxo-1
CAS:
108138-46-1
MF:
C19H15F3N4O3
MW:
404.34
Product Categories:
  • Tosufloxacin
  • Active Pharmaceutical Ingredients
Mol File:
108138-46-1.mol
More
Less

Tosufloxacin Chemical Properties

CAS DataBase Reference
108138-46-1(CAS DataBase Reference)
More
Less

Tosufloxacin Usage And Synthesis

Uses

Tosufloxacin Tosilate (CAS# 100490-36-6) was identified in a Haemophilus influenza clone ST422.

Definition

ChEBI: 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid is a 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively. It is a 1,8-naphthyridine derivative, an amino acid, a monocarboxylic acid, an organofluorine compound, an aminopyrrolidine, a tertiary amino compound, a primary amino compound and a quinolone antibiotic. It is a conjugate base of a 1-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5-oxo-5,8-dihydro-1,8-naphthyridin-2-yl]pyrrolidin-3-aminium.

brand name

Tosufloxacin Tosilate is JAN.

Pharmaceutical Applications

It is active against a wide range of Gram-positive and Gram-negative bacteria, including Acinetobacter spp., L. pneumophila and Campylobacter spp. Unlike many quinolones it is moderately active against L. monocytogenes. C. trachomatis is also moderately susceptible. It is active against some anaerobes, including the B. fragilis group. Activity against Mycobacterium spp. is limited. It is well absorbed by the oral route, achieving a plasma concentration of c. 1 mg/L 4 h after a 300 mg dose. Around 30–35% of the dose is eliminated in the urine, with an apparent elimination half-life of 6–7 h.
Clinical experience is limited, but high clinical and bacteriological cure rates have been obtained in patients with skin and soft-tissue infections.

Tosufloxacin Preparation Products And Raw materials

Preparation Products

TosufloxacinSupplier

Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Email
waley188@sohu.com
Guangzhou Isun Pharmaceutical Co., Ltd
Tel
020-39119399 18927568969
Email
isunpharm@qq.com
Wuhan DKY Technology Co.,Ltd.
Tel
27-81302488 18007166089
Email
info@dkybpc.com
SPIRO PHARMA
Tel
Email
eric_feng1954@126.com
Raw material medicin reagent co.,Ltd
Tel
Email
sales@njromanme.com